Error: Could not add to watchlist. X
+ Watchlist

Anadys Pharmaceuticals Inc

ANDS:US
Acquired
ANDS:US was acquired by ROG:VX
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.51
Market Cap (USD)
-
Shares Outstanding (m)
57.438
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Anadys Pharmaceuticals Inc. provides biopharmaceuticals. The Company discovers, develops, and commercializes small molecule, anti-infective medicines for the treatment of hepatitis C virus, or HCV, and bacterial infections.
Address
5871 Oberlin Drive
Suite 200
San Diego, CA 92121
United States
Phone
1-858-530-3600
Website
-